41 related articles for article (PubMed ID: 26426296)
1. Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.
Childress ES; Kharel Y; Brown AM; Bevan DR; Lynch KR; Santos WL
J Med Chem; 2017 May; 60(9):3933-3957. PubMed ID: 28406646
[TBL] [Abstract][Full Text] [Related]
2. A High-Throughput Screening-Compatible Strategy for the Identification of Inositol Pyrophosphate Kinase Inhibitors.
Baughman BM; Wang H; An Y; Kireev D; Stashko MA; Jessen HJ; Pearce KH; Frye SV; Shears SB
PLoS One; 2016; 11(10):e0164378. PubMed ID: 27736936
[TBL] [Abstract][Full Text] [Related]
3. Investigating potential of cholic acid, syringic acid, and mangiferin as cancer therapeutics through sphingosine kinase 1 inhibition.
Shakeel I; Khan S; Roy S; Sherwani F; Ahmad SF; Sohal SS; Afzal M; Hassan MI
Int J Biol Macromol; 2023 Dec; 253(Pt 5):127036. PubMed ID: 37788733
[TBL] [Abstract][Full Text] [Related]
4. Discovering Gummadiol and Isoarboreol as potential inhibitors of sphingosine kinase 1: virtual screening and MD simulation studies.
Elasbali AM; Al-Soud WA; Alhassan HH; Mousa Elayyan AE; Kamal M; Alanazi H; Alharbi B; Alharethi SH; Mohamed BM
J Biomol Struct Dyn; 2023; 41(22):12789-12797. PubMed ID: 36644886
[TBL] [Abstract][Full Text] [Related]
5. Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of
Roy S; Mahapatra AD; Mohammad T; Gupta P; Alajmi MF; Hussain A; Rehman MT; Datta B; Hassan MI
Pharmaceuticals (Basel); 2020 Jun; 13(6):. PubMed ID: 32526899
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screening system for inhibitors of human Heat Shock Factor 2.
Smith LM; Bhattacharya D; Williams DJ; Dixon I; Powell NR; Erkina TY; Erkine AM
Cell Stress Chaperones; 2015 Sep; 20(5):833-41. PubMed ID: 26003133
[TBL] [Abstract][Full Text] [Related]
7. A direct fluorometric activity assay for lipid kinases and phosphatases.
Sun J; Singaram I; Soflaee MH; Cho W
J Lipid Res; 2020 Jun; 61(6):945-952. PubMed ID: 32341006
[TBL] [Abstract][Full Text] [Related]
8. Semi-Automated High-Throughput Substrate Screening Assay for Nucleoside Kinases.
Hellendahl KF; Fehlau M; Hans S; Neubauer P; Kurreck A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768989
[TBL] [Abstract][Full Text] [Related]
9. High Throughput Glycerate Kinase Activity Assay Using Crude Leaf Extract and Recombinant Enzyme to Determine Kinetic Parameters K
Roze LV; Johnson A; Walker BJ
Methods Mol Biol; 2024; 2792():83-95. PubMed ID: 38861080
[TBL] [Abstract][Full Text] [Related]
10. Yeast as a tool to identify anti-aging compounds.
Zimmermann A; Hofer S; Pendl T; Kainz K; Madeo F; Carmona-Gutierrez D
FEMS Yeast Res; 2018 Sep; 18(6):. PubMed ID: 29905792
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors.
Congdon MD; Childress ES; Patwardhan NN; Gumkowski J; Morris EA; Kharel Y; Lynch KR; Santos WL
Bioorg Med Chem Lett; 2015 Nov; 25(21):4956-4960. PubMed ID: 25862200
[TBL] [Abstract][Full Text] [Related]
12. Saccharomyces cerevisiae as a platform for assessing sphingolipid lipid kinase inhibitors.
Kharel Y; Agah S; Huang T; Mendelson AJ; Eletu OT; Barkey-Bircann P; Gesualdi J; Smith JS; Santos WL; Lynch KR
PLoS One; 2018; 13(4):e0192179. PubMed ID: 29672528
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
Lynch KR; Thorpe SB; Santos WL
Expert Opin Ther Pat; 2016 Dec; 26(12):1409-1416. PubMed ID: 27539678
[TBL] [Abstract][Full Text] [Related]
14. Design of Sphingosine Kinases Inhibitors: Challenges and Recent Developments.
Magli E; Corvino A; Fiorino F; Frecentese F; Perissutti E; Saccone I; Santagada V; Caliendo G; Severino B
Curr Pharm Des; 2019; 25(9):956-968. PubMed ID: 30947653
[TBL] [Abstract][Full Text] [Related]
15. A High-Throughput Genetic Complementation Assay in Yeast Cells Identified Selective Inhibitors of Sphingosine Kinase 1 Not Found Using a Cell-Free Enzyme Assay.
Kashem MA; Kennedy CA; Fogarty KE; Dimock JR; Zhang Y; Sanville-Ross ML; Skow DJ; Brunette SR; Swantek JL; Hummel HS; Swindle J; Nelson RM
Assay Drug Dev Technol; 2016; 14(1):39-49. PubMed ID: 26426296
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
